190 related articles for article (PubMed ID: 34887255)
1. Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor.
Kim M; Gupta SK; Zhang W; Talele S; Mohammad AS; Laramy J; Mladek AC; Zhang S; Sarkaria JN; Elmquist WF
Drug Metab Dispos; 2022 Mar; 50(3):277-286. PubMed ID: 34887255
[TBL] [Abstract][Full Text] [Related]
2. ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.
Zhang Y; Bressler JP; Neal J; Lal B; Bhang HE; Laterra J; Pomper MG
Cancer Res; 2007 Oct; 67(19):9389-97. PubMed ID: 17909048
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Bioluminescent Substrates in Natural Infection Models of Neglected Parasitic Diseases.
Hendrickx S; Bulté D; Mabille D; Mols R; Claes M; Ilbeigi K; Ahmad R; Dirkx L; Van Acker SI; Caljon G
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555716
[TBL] [Abstract][Full Text] [Related]
4. A synthetic luciferin improves in vivo bioluminescence imaging of gene expression in cardiovascular brain regions.
Simonyan H; Hurr C; Young CN
Physiol Genomics; 2016 Oct; 48(10):762-770. PubMed ID: 27614203
[TBL] [Abstract][Full Text] [Related]
5. Bioluminescence imaging in mice with synthetic luciferin analogues.
Ji X; Adams ST; Miller SC
Methods Enzymol; 2020; 640():165-183. PubMed ID: 32560797
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Brightness and Spectral Properties of Click Beetle and Firefly Luciferases Using Luciferin Analogues: Identification of Preferred Pairings of Luciferase and Substrate for In Vivo Bioluminescence Imaging.
Zambito G; Gaspar N; Ridwan Y; Hall MP; Shi C; Kirkland TA; Encell LP; Löwik C; Mezzanotte L
Mol Imaging Biol; 2020 Dec; 22(6):1523-1531. PubMed ID: 32926287
[TBL] [Abstract][Full Text] [Related]
7. Uptake kinetics and biodistribution of 14C-D-luciferin--a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging.
Berger F; Paulmurugan R; Bhaumik S; Gambhir SS
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2275-85. PubMed ID: 18661130
[TBL] [Abstract][Full Text] [Related]
8. A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging.
Kuchimaru T; Iwano S; Kiyama M; Mitsumata S; Kadonosono T; Niwa H; Maki S; Kizaka-Kondoh S
Nat Commun; 2016 Jun; 7():11856. PubMed ID: 27297211
[TBL] [Abstract][Full Text] [Related]
9. Bioluminescent imaging of drug efflux at the blood-brain barrier mediated by the transporter ABCG2.
Bakhsheshian J; Wei BR; Chang KE; Shukla S; Ambudkar SV; Simpson RM; Gottesman MM; Hall MD
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20801-6. PubMed ID: 24297888
[TBL] [Abstract][Full Text] [Related]
10. A synthetic luciferin improves bioluminescence imaging in live mice.
Evans MS; Chaurette JP; Adams ST; Reddy GR; Paley MA; Aronin N; Prescher JA; Miller SC
Nat Methods; 2014 Apr; 11(4):393-5. PubMed ID: 24509630
[TBL] [Abstract][Full Text] [Related]
11. Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms.
Zhang Y; Pullambhatla M; Laterra J; Pomper MG
Mol Imaging; 2012; 11(6):499-506. PubMed ID: 23084250
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine upregulates ABCG2/BCRP and modulates the intracellular pharmacokinetic profiles of bioluminescence in pancreatic cancer cells.
Sun Y; Gu M; Zhu L; Liu J; Xiong Y; Wei Y; Li F
Anticancer Drugs; 2016 Mar; 27(3):183-91. PubMed ID: 26556627
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Bioluminescent Imaging of ATP-Binding Cassette Transporter-Mediated Efflux at the Blood-Brain Barrier.
Bakhsheshian J; Wei BR; Hall MD; Simpson RM; Gottesman MM
Methods Mol Biol; 2016; 1461():227-39. PubMed ID: 27424909
[TBL] [Abstract][Full Text] [Related]
14. Firefly Luciferase Mutants Allow Substrate-Selective Bioluminescence Imaging in the Mouse Brain.
Adams ST; Mofford DM; Reddy GS; Miller SC
Angew Chem Int Ed Engl; 2016 Apr; 55(16):4943-6. PubMed ID: 26991209
[TBL] [Abstract][Full Text] [Related]
15. Aminoluciferins extend firefly luciferase bioluminescence into the near-infrared and can be preferred substrates over D-luciferin.
Mofford DM; Reddy GR; Miller SC
J Am Chem Soc; 2014 Sep; 136(38):13277-82. PubMed ID: 25208457
[TBL] [Abstract][Full Text] [Related]
16. Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.
Gross S; Abraham U; Prior JL; Herzog ED; Piwnica-Worms D
Mol Imaging; 2007; 6(2):121-30. PubMed ID: 17445506
[TBL] [Abstract][Full Text] [Related]
17. A biocompatible in vivo ligation reaction and its application for noninvasive bioluminescent imaging of protease activity in living mice.
Godinat A; Park HM; Miller SC; Cheng K; Hanahan D; Sanman LE; Bogyo M; Yu A; Nikitin GF; Stahl A; Dubikovskaya EA
ACS Chem Biol; 2013 May; 8(5):987-99. PubMed ID: 23463944
[TBL] [Abstract][Full Text] [Related]
18. How to Select Firefly Luciferin Analogues for In Vivo Imaging.
Saito-Moriya R; Nakayama J; Kamiya G; Kitada N; Obata R; Maki SA; Aoyama H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673331
[TBL] [Abstract][Full Text] [Related]
19. Optimized Longitudinal Monitoring of Stem Cell Grafts in Mouse Brain Using a Novel Bioluminescent/Near Infrared Fluorescent Fusion Reporter.
Mezzanotte L; Iljas JD; Que I; Chan A; Kaijzel E; Hoeben R; Löwik C
Cell Transplant; 2017 Dec; 26(12):1878-1889. PubMed ID: 29390874
[TBL] [Abstract][Full Text] [Related]
20. Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.
Zhang Y; Byun Y; Ren YR; Liu JO; Laterra J; Pomper MG
Cancer Res; 2009 Jul; 69(14):5867-75. PubMed ID: 19567678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
